BP is going to hand these guys money and a lot of it with this management team in place you are dead wrong. When a BP makes an investment in a little company they are investing in the PEOPLE at that company as well as the science, unless of course they'll be sending some of their employees to run PPHM the right way.
Think Immunex, I heard the same thing abuuot Immunex.
But in the end Enbrel was just too fine a drug and now they are Amgen....Before that they Were AHP (wyeth)
If Bavi works, the same will happen.
By the way, Immunex was ALWAYS a money losing R&D Boutique company and during their PHI-II's for enbrel it went from $12.00 to $4.00 for no reason....Heard the same things as I am hearing now. Why is that?
News 
Market Data 
Discover 
AI
